×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
NRXP – nrx pharmaceuticals, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
NRXP
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/24
04:15 pm
nrxp
NRx Pharmaceuticals (NASDAQ:NRXP) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Medium
Report
NRx Pharmaceuticals (NASDAQ:NRXP) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
12/18
04:39 pm
nrxp
NRx Pharmaceuticals (NASDAQ:NRXP) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Medium
Report
NRx Pharmaceuticals (NASDAQ:NRXP) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
12/18
07:32 am
nrxp
NRx Pharmaceuticals (Nasdaq:NRXP) announces elimination of all balance sheet debt following equity conversion [Yahoo! Finance]
Medium
Report
NRx Pharmaceuticals (Nasdaq:NRXP) announces elimination of all balance sheet debt following equity conversion [Yahoo! Finance]
12/18
07:05 am
nrxp
NRx Pharmaceuticals (Nasdaq:NRXP) announces elimination of all balance sheet debt following equity conversion
Medium
Report
NRx Pharmaceuticals (Nasdaq:NRXP) announces elimination of all balance sheet debt following equity conversion
12/16
08:05 am
nrxp
NRx Pharmaceuticals (NASDAQ:NRXP) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock.
High
Report
NRx Pharmaceuticals (NASDAQ:NRXP) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock.
12/3
08:06 am
nrxp
NRx Pharmaceuticals (NASDAQ:NRXP) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $25.00 price target on the stock.
Low
Report
NRx Pharmaceuticals (NASDAQ:NRXP) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $25.00 price target on the stock.
12/3
07:00 am
nrxp
NRx Pharmaceuticals to discuss new NRX-101 pipeline indication for augmentation of Transcranial Magnetic Stimulation
Medium
Report
NRx Pharmaceuticals to discuss new NRX-101 pipeline indication for augmentation of Transcranial Magnetic Stimulation
12/2
07:07 pm
nrxp
NRx Pharmaceuticals (NRXP) Announces FDA Receipt of ANDA for KETAFREE With July 2026 Review Goal Date [Yahoo! Finance]
Medium
Report
NRx Pharmaceuticals (NRXP) Announces FDA Receipt of ANDA for KETAFREE With July 2026 Review Goal Date [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
11/14/2025
04:32 pm
nrxp
nrx pharmaceuticals, inc.
MISS
Report
-13.2%
nrx pharmaceuticals, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/23
06:03 am
nrxp
Form EFFECT NRX Pharmaceuticals,
Low
Report
Form EFFECT NRX Pharmaceuticals,
12/22
05:17 pm
nrxp
Form 424B3 NRX Pharmaceuticals,
Low
Report
Form 424B3 NRX Pharmaceuticals,
12/12
04:31 pm
nrxp
Form S-3/A NRX Pharmaceuticals,
Medium
Report
Form S-3/A NRX Pharmaceuticals,
11/26
04:31 pm
nrxp
Form 8-K NRX Pharmaceuticals, For: Nov 20
Medium
Report
Form 8-K NRX Pharmaceuticals, For: Nov 20
11/21
04:32 pm
nrxp
Form 8-K/A NRX Pharmaceuticals, For: Sep 08
Medium
Report
Form 8-K/A NRX Pharmaceuticals, For: Sep 08
11/14
04:41 pm
nrxp
Form 10-Q NRX Pharmaceuticals, For: Sep 30
High
Report
Form 10-Q NRX Pharmaceuticals, For: Sep 30
10/23
04:31 pm
nrxp
Form 8-K NRX Pharmaceuticals, For: Oct 17
Low
Report
Form 8-K NRX Pharmaceuticals, For: Oct 17
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: